Lista de obras -

A consensus statement on the gender perspective in lung cancer.

artículo científico publicado en 2016

A survey of perceptions, attitudes, knowledge and practices of medical oncologists about cancer pain management in Spain

artículo científico publicado en 2018

Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry

artículo científico publicado en 2014

Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study

artículo científico publicado en 2018

Aligning Digital CD8(+) Scoring and Targeted Next-Generation Sequencing with PD-L1 Expression: A Pragmatic Approach in Early-Stage Squamous Cell Lung Carcinoma

artículo científico publicado en 2017

An epigenomic approach to identifying differential overlapping and cis-acting lncRNAs in cisplatin-resistant cancer cells.

artículo científico publicado en 2018

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING Study

artículo científico publicado en 2019

Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study

scientific article published on 09 April 2020

Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

artículo científico publicado en 2014

Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation.

artículo científico publicado en 2010

Can This Patient Be Discharged Home? Factors Associated With At-Home Death Among Patients With Cancer ⬇️

artículo científico publicado el 22 de febrero de 2011

Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter study.

artículo científico publicado en 2015

Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary

scientific article published on 29 January 2013

Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance

scientific article published on 30 May 2019

Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping

scientific article published on 01 February 2019

Clinical-molecular factors predicting response and survival for tyrosine-kinase inhibitors.

artículo científico publicado en 2009

Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer.

artículo científico publicado en 2016

DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through MAFG Overexpression in Cancer Cells

artículo científico publicado en 2017

Effectiveness of home single-channel nasal pressure for sleep apnea diagnosis

artículo científico publicado en 2014

Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database.

artículo científico publicado en 2017

Expression patterns for nicotinic acetylcholine receptor subunit genes in smoking-related lung cancers.

artículo científico publicado en 2017

Foot pain: uncommon presentation of lung cancer.

artículo científico publicado en 2012

Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study

artículo científico publicado en 2018

Hypermethylation of Anti-oncogenic MicroRNA 7 is Increased in Emphysema Patients

artículo científico publicado en 2019

Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy.

artículo científico publicado en 2011

Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers

scientific article published on 20 November 2020

Iron deficiency in patients with solid tumours: prevalence and management in clinical practice.

artículo científico publicado en 2014

Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy

artículo científico publicado en 2016

Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07.

artículo científico publicado en 2016

Lung cancer in women: an overview with special focus on Spanish women

artículo científico publicado en 2013

MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species

artículo científico publicado en 2018

MALDI profiling of human lung cancer subtypes.

artículo científico publicado en 2009

Management Difficulties in a Patient with EGFR-mutation Positive Lung Adenocarcinoma and Cerebral Metastases.

artículo científico publicado en 2016

Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapy.

artículo científico publicado en 2014

Molecular markers to predict outcome to antiangiogenic therapies in colorectal cancer: current evidence and future perspectives.

artículo científico

Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study

scientific article published in PLoS ONE

Monoclonal antibodies for medical oncology: a few critical perspectives ⬇️

artículo científico publicado el 1 de febrero de 2011

Optimization of oral chemotherapy in outpatient clinics in Spain: results from a survey of the Spanish Society of Medical Oncology (SEOM)

article

Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer

artículo científico publicado en 2019

Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression

scientific article published on 02 March 2014

Randomized phase IIIb trial evaluating the continuation of bevacizumab beyond disease progression in patients with advanced non-squamous non-small-cell lung cancer after first-line treatment with bevacizumab plus platinum-based chemotherapy: treatme

artículo científico publicado en 2011

Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology.

artículo científico publicado en 2014

Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer.

artículo científico publicado en 2014

Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer

artículo científico publicado en 2019

SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016).

artículo científico publicado en 2016

SEOM clinical guidelines for myeloid growth factors

artículo científico publicado en 2012

Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin–gemcitabine–vinorelbine. A phase II study ⬇️

artículo científico publicado el 1 de octubre de 2001

Small Cell Breast Cancer with Lung Metastases

scientific article published on 09 April 2018

Strategies for maintenance therapy in advanced non-small cell lung cancer: current status, unanswered questions and future directions.

artículo científico publicado en 2011

Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study

artículo científico publicado en 2017

The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative Group

artículo científico publicado el 1 de septiembre de 1997

Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications

artículo científico publicado en 2015

Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus

artículo científico publicado en 2019

Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

artículo científico publicado en 2019

[Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology]

artículo científico publicado en 2014

miR-7 methylation as a biomarker to predict poor survival in early-stage non-small cell lung cancer patients

artículo científico publicado en 2019

Lista de obras de

A consensus statement on the gender perspective in lung cancer.

A survey of perceptions, attitudes, knowledge and practices of medical oncologists about cancer pain management in Spain

Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry

Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study

Aligning Digital CD8(+) Scoring and Targeted Next-Generation Sequencing with PD-L1 Expression: A Pragmatic Approach in Early-Stage Squamous Cell Lung Carcinoma

An epigenomic approach to identifying differential overlapping and cis-acting lncRNAs in cisplatin-resistant cancer cells.

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING Study

Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study

Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation.

Can This Patient Be Discharged Home? Factors Associated With At-Home Death Among Patients With Cancer ⬇️

Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter study.

Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary

Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance

Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping

Clinical-molecular factors predicting response and survival for tyrosine-kinase inhibitors.

Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer.

DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through MAFG Overexpression in Cancer Cells

Effectiveness of home single-channel nasal pressure for sleep apnea diagnosis

Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database.

Expression patterns for nicotinic acetylcholine receptor subunit genes in smoking-related lung cancers.

Foot pain: uncommon presentation of lung cancer.

Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study

Hypermethylation of Anti-oncogenic MicroRNA 7 is Increased in Emphysema Patients

Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy.

Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers

Iron deficiency in patients with solid tumours: prevalence and management in clinical practice.

Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy

Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07.

Lung cancer in women: an overview with special focus on Spanish women

MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species

MALDI profiling of human lung cancer subtypes.

Management Difficulties in a Patient with EGFR-mutation Positive Lung Adenocarcinoma and Cerebral Metastases.

Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapy.

Molecular markers to predict outcome to antiangiogenic therapies in colorectal cancer: current evidence and future perspectives.

Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study

Monoclonal antibodies for medical oncology: a few critical perspectives ⬇️

Optimization of oral chemotherapy in outpatient clinics in Spain: results from a survey of the Spanish Society of Medical Oncology (SEOM)

Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer

Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression

Randomized phase IIIb trial evaluating the continuation of bevacizumab beyond disease progression in patients with advanced non-squamous non-small-cell lung cancer after first-line treatment with bevacizumab plus platinum-based chemotherapy: treatme

Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology.

Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer.

Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer

SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016).

SEOM clinical guidelines for myeloid growth factors

Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin–gemcitabine–vinorelbine. A phase II study ⬇️

Small Cell Breast Cancer with Lung Metastases

Strategies for maintenance therapy in advanced non-small cell lung cancer: current status, unanswered questions and future directions.

Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study

The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative Group

Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications

Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus

Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

[Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology]

miR-7 methylation as a biomarker to predict poor survival in early-stage non-small cell lung cancer patients